Your browser doesn't support javascript.
loading
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study.
Verdegaal, Els; van der Kooij, Monique K; Visser, Marten; van der Minne, Caroline; de Bruin, Linda; Meij, Pauline; Terwisscha van Scheltinga, Anton; Welters, Marij J; Santegoets, Saskia; de Miranda, Noel; Roozen, Inge; Liefers, Gerrit Jan; Kapiteijn, Ellen; van der Burg, Sjoerd H.
Afiliación
  • Verdegaal E; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands e.m.e.verdegaal@lumc.nl.
  • van der Kooij MK; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Visser M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Minne C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • de Bruin L; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Meij P; GMP Facility Leiden, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Terwisscha van Scheltinga A; GMP Facility Leiden, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Welters MJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Santegoets S; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • de Miranda N; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Roozen I; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Liefers GJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
J Immunother Cancer ; 8(1)2020 03.
Article en En | MEDLINE | ID: mdl-32238469
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Interferón-alfa / Tratamiento Basado en Trasplante de Células y Tejidos / Inmunoterapia Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Interferón-alfa / Tratamiento Basado en Trasplante de Células y Tejidos / Inmunoterapia Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article